Cosmo Pharmaceuticals €175 million 2.5% bond issue

5/12/2018
Investment grade bond/note issue

€ 175 million

$ 195.079 million

Announced

5/12/2018


Overview:

  • Pharmaceutical company Cosmo Pharmaceuticals has issued a €175 million 2.5% bond, due to mature in 2023.

Prin Shasiharan - Researcher

Jurisdictions:

Luxembourg
Netherlands
Switzerland
United Kingdom

Deal type:

Investment grade bond/note issue

Practice area:

Capital markets : Debt

Industry sector:

Pharmaceuticals and life sciences


Firm:

Party: Cosmo Pharmaceuticals (Issuer)